Physician

Abid Majid, MD

According to 2025 Medicare claims, Abid Majid, MD (NPI: 1902828486) practices critical care (intensivists) in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is SERRAMONTE PULMONARY, ASTHMA SLEEP CLINIC INC. (NPI: 1588949416; TIN: 273311559) and primary practice location at 94545-9998.

Majid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 694 traditional Medicare patients, billed 3,072 HCPCS/CPT codes, and received $336,115 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,372 prescription claims across 257 beneficiaries totaling $829,094 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 2,142 claims. Open Payments data shows 89 records totaling $2,166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $106,509 to $336,115. Similarly, Part D prescription costs have risen steadily, from $54,099 to $829,094. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	309	889	$106,509
2016	429	2,083	$215,245
2017	400	1,395	$165,542
2018	431	1,626	$206,924
2019	330	1,636	$187,169
2020	478	2,038	$251,656
2021	469	2,135	$254,841
2022	422	1,731	$204,360
2023	434	1,893	$245,255
2024	694	3,072	$336,115

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	77	332	$54,099
2016	124	525	$101,996
2017	111	508	$119,100
2018	137	554	$161,953
2019	162	804	$313,941
2020	142	914	$457,400
2021	148	1,004	$811,999
2022	126	854	$584,195
2023	118	775	$367,963
2024	257	1,372	$829,094

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	331	1,067	$45,394
2016	613	1,328	$82,624
2017	813	2,225	$153,771
2018	1,129	2,803	$182,133
2019	1,287	3,315	$196,153
2020	1,076	2,709	$105,582
2021	911	2,326	$126,687
2022	820	2,076	$141,374
2023	758	1,905	$118,963
2024	867	2,142	$141,081

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	201	546	$173
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	248	508	$109
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	224	500	$99
99292	Critical care, each additional 30 minutes	148	216	$87
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	150	381	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	28	820	$327,197
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	155	5,700	$113,607
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	45	2,550	$50,506
Breo Ellipta	Fluticasone/Vilanterol	55	2,580	$31,766
Spiriva Respimat	Tiotropium Bromide	21	690	$11,695

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	46	$38,176
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	32	$27,472
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	25	159	$11,624
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	76	153	$7,752
A7030	Full face mask used with positive airway pressure device, each	N	47	96	$6,901

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	89	$2,166	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abid Majid, MD?

Tedicare shows public-source Medicare data for Abid Majid, MD (NPI 1902828486), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abid Majid, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abid Majid, MD?

Abid Majid, MD is linked to SERRAMONTE PULMONARY, ASTHMA SLEEP CLINIC INC. (billing NPI 1588949416) in the available physician profile data.

Does Abid Majid, MD have Open Payments data?

Abid Majid, MD has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.